Diagnostics / Life Sciences M&A Valuation Segment Report
Comparable Transactions / Precedent Deals
 
Excel spreadsheet with Scope Research's diagnostics and life sciences M&A valuation data and benchmarking tools. Transactions are segmented by type, which include a variety of laboratories, diagnostic tools, and life sciences equipment providers.
 
242 transactions with revenue or EBITDA multiples (since 2010)
106 of these deals have reported EBITDA multiples
Last updated 6/1/2026
 
Each transaction includes price to revenue and/or EBITDA multiples. We provide the names of the parties, transaction date, ownership percentage acquired, deal price (stated on a total enterprise value basis), time period of the financial information relied upon, revenue and/or EBITDA, and a description of our source documents and key details related to the financial information presented. 

Reach out to will@scoperesearch.co for more information.

All transactions included in the Scope Research healthcare M&A valuation database are meticulously researched and sourced. Our internal records include an audit trail of links to the majority of our sources.